Pharmaceutical Industry in Mexico

  • ID: 481974
  • Report
  • Region: Mexico
  • 160 Pages
  • Aruvian's R'search
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
Mexico’s pharmaceutical policy environment is in a period of rapid evolution, with simultaneous policy development, refinement and ongoing implementation. This handicaps Mexico’s efforts to achieve policy goals efficiently at the present time, and also makes policy assessment and even accurate description difficult.

Mexico, along with almost all OECD countries, has witnessed growth rates in health expenditures that have surpassed general rates of inflation and, as in many cases, a main driver has been spending on pharmaceuticals. Like most OECD countries, annual growth in pharmaceutical expenditures in Mexico was greater than that for total health spending (net of pharmaceutical spending).

This research brings you a complete analysis of the Pharmaceutical Industry in Mexico. The report covers a brief profile of the global pharmaceutical industry, the trends in the industry, competition in the industry, and key trends in the pharmaceutical supply chain in Mexico. The report also looks at strategies for market entry, the role of R&D in the Mexican Pharmaceutical Industry, and the role of the government in the industry.

Complete with a comprehensive section on the clinical trials, market investment opportunities going on in the Mexican pharmaceutical industry, Aruvians’ latest research is a collection of all you need to know about Mexico’s Pharmaceutical Industry.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
A. Executive Summary

B. Global Pharmaceutical Industry - A Brief Profile
B.1 Industry Definition
B.2 Industry Overview
B.3 Competition in the Global Pharmaceutical Industry
B.4 Industry Forecast

C. Mexico’s Pharmaceutical Industry
C.1 Industry Overview
C.2 Industry Value
C.3 Market Segments
C.4 Market Share Analysis
C.5 Competition in the Industry
C.6 Pharmaceutical Expenditure
C.7 Industry Activity
C.8 Distribution Channels
C.9 R&D in the Industry
C.10 Clinical Trials
C.11 Emergence of Pharmacogenomics
C.12 Pharmaceutical Supply Chain
C.13 Demand Scenario for Pharmaceuticals
C.14 Import/Export Scenario

D. Mexico’s OTC Pharmaceutical Sector
D.1 Sector Definition
D.2 Industry Overview
D.3 Industry Value
D.4 Market Segments
D.5 Market Share
D.6 Competition in the Industry
D.7 Distribution Channels
D.8 Sector Forecast

E. Pharmaceutical Pricing and Reimbursement in Mexico
E.1 Mexico’s Regulatory Environment
E.2 Intellectual Property Rights
E.3 Product Approval Process
E.4 Pricing Policies
E.5 Coverage Scheme for Pharmaceuticals
E.6 Purchasing of Pharmaceuticals
E.7 Initiatives Influencing Pharmaceutical Consumption

F. Industry Forecast

G. Major Players
G.1 Abbott Laboratories
G.1.1 Corporate Profile
G.1.2 Business Segment Analysis
G.1.3 Financial Analysis
G.1.4 SWOT Analysis
G.2 Bayer AG
G.2.1 Corporate Profile
G.2.2 Business Segment Analysis
G.2.3 Financial Analysis
G.2.4 SWOT Analysis
G.3 Boehringer Ingelheim GmbH
G.3.1 Corporate Profile
G.3.2 Business Segment Analysis
G.3.3 Financial Analysis
G.3.4 SWOT Analysis
G.4 Eli Lilly & Co
G.4.1 Corporate Profile
G.4.2 Business Segment Analysis
G.4.3 Financial Analysis
G.4.4 SWOT Analysis
G.5 GlaxoSmithKline Plc
G.5.1 Corporate Profile
G.5.2 Business Segment Analysis
G.5.3 Financial Analysis
G.5.4 SWOT Analysis
G.6 Johnson & Johnson
G.6.1 Corporate Profile
G.6.2 Business Segment Analysis
G.6.3 Financial Analysis
G.6.4 SWOT Analysis
G.7 Koninklijke DSM N.V.
G.7.1 Corporate Profile
G.7.2 Business Segment Analysis
G.7.3 Financial Analysis
G.7.4 SWOT Analysis
G.8 Pfizer
G.8.1 Corporate Profile
G.8.2 Business Segment Analysis
G.8.3 Financial Analysis
G.8.4 SWOT Analysis

G. Glossary of Terms

List of Figures

Figure 1: Geographic Segmentation of the Mexican Pharmaceutical Industry (%), 2014
Figure 2: Major Players in the Mexican Pharmaceutical Industry & their Market Share (%), 2014
Figure 3: Value of the OTC Market in Mexico (in USD Million), 2010-2014
Figure 4: Mexico OTC Market Segmentation (%), 2014
Figure 5: Share of Mexico's OTC Market in the Americas (%), 2014
Figure 6: Market Share of the Mexico OTC Industry (%), 2014
Figure 7: Share of the Mexican OTC Market by Distribution Channels (%), 2014
Figure 8: Forecast for the Mexican OTC Market (in USD Million), 2014-2019

List of Tables

Table 1: Mexican Pharmaceutical Industry Value (in USD Billion), 2010-2014
Table 2: Value of the OTC Market in Mexico (in USD Million), 2010-2014
Table 3: Mexico OTC Pharmaceuticals Market Segmentation, Value in USD Million & %, 2014
Table 4: Share of Mexico OTC Market in the Americas (in USD Million & %), 2014
Table 5: Forecast for the Mexican OTC Market (in USD Million), 2014-2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Abbott Laboratories
Bayer AG
Boehringer Ingelheim GmbH
Eli Lilly & Co
GlaxoSmithKline Plc
Johnson & Johnson
Koninklijke DSM N.V.
Pfizer
Note: Product cover images may vary from those shown
5 of 4
Question Does the report break out market size for the Government and Private sectors?
Answer The report does not cover the market size based on the government and private sectors.
Note: Product cover images may vary from those shown
Adroll
adroll